A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease

Clinical Therapeutics

Volumn 28, Issue 12, 2006, Pages 1983-1988

  Rahimi, Roja ^a   Nikfar, Shekoufeh ^b   Rezaie, Ali ^c   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Food and Drug Organization   (Iran)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

broad spectrum antibiotics, Crohn's disease, meta analysis, inflammatory bowel disease, clinical improvement

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PLACEBO; PREDNISONE; SALAZOSULFAPYRIDINE;

CLINICAL TRIAL; CROHN DISEASE; DRUG EFFICACY; HUMAN; MEDLINE; RANDOMIZATION; REVIEW; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPROTOZOAL AGENTS; CROHN DISEASE; DRUG THERAPY, COMBINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33846798073     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.12.012     Document Type: Review

References (28)

1. Atzeni F., Ardizzone S., Sarzi-Puttini P., et al. Autoantibody profile during short-term infliximab treatment for Crohn's disease: A prospective cohort study. Aliment Pharmacol Ther 22 (2005) 453-461
2. Griffiths A.M., and Buller H.B. Inflammatory bowel disease. In: Walker W.A., Hamilton J.R., Walker-Smith J.A., and Watkins J.B. (Eds). Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management (2000), BC Decker, Hamilton, Ontario 613-652
3. Jahanshahi G., Motavasel V., Rezaie A., et al. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci 49 (2004) 1752-1757
4. Luxembourg, Belgium. Abstract 17. Ghorbani F., Eshghtork A., Rezaie A., et al. Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-β in relation to disease activity in Crohn's disease patients. Paper presented at: Cell Signaling World 2006 (January 25-28, 2006)
5. Kruis W. Review article: Antibiotics and probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 20 Suppl 4 (2004) 75-78
6. Sartor R.B. Targeting enteric bacteria in treatment of inflammatory bowel diseases: Why, how, and when. Curr Opin Gastroenterol 19 (2003) 358-365
7. Isaacs K.L., and Sartor R.B. Treatment of inflammatory bowel disease with antibiotics. Gastroenterol Clin North Am 33 (2004) 335-345
8. Colombel J.F., Cortot A., and van Kruiningen H.J. Antibiotics in Crohn's disease. Gut 48 (2001) 647
9. Schultz M., Scholmerich J., and Rath H.C. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases. Dig Dis 21 (2003) 105-128
10. Shanahan F., and Bernstein C.N. Antibiotics as a first-line therapy for Crohn's disease: Is there any con sensus?. Inflamm Bowel Dis 10 (2004) 324-326
11. Wild G.E. The role of antibiotics in the management of Crohn's disease. Inflamm Bowel Dis 10 (2004) 321-323
12. Greenberg G.R. Antibiotics should be used as first-line therapy for Crohn's disease. Inflamm Bowel Dis 10 (2004) 318-320
13. Borgaonkar M.R., Macintosh D.G., and Fardy J.M. A meta-analysis of antimycobacterial therapy for Crohn's disease. Am J Gastroenterol 95 (2000) 725-729
14. Blichfeldt P., Blomhoff J.P., Myhre E., and Gjone E. Metronidazole in Crohn's disease. A double blind cross-over clinical trial. Scand J Gastroenterol 13 (1978) 123-127
15. Ambrose N.S., Allan R.N., Keighley M.R., et al. Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. A prospective randomized study. Dis Colon Rectum 28 (1985) 81-85
16. Sutherland L., Singleton J., Sessions J., et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 32 (1991) 1071-1075
17. Steinhart A.H., Feagan B.G., Wong C.J., et al. Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial. Gastroenterology 123 (2002) 33-40
18. Arnold G.L., Beaves M.R., Pryjdun V.O., and Mook W.J. Preliminary study of ciprofloxacin in active Crohn's disease. Inflamm Bowel Dis 8 (2002) 10-15
19. West R.L., van der Woude C.J., Hansen B.E., et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: A double-blind placebo-controlled study. Aliment Pharmacol Ther 20 (2004) 1329-1336
20. Hudson M.J., Hill M.J., Elliott P.R., et al. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy. J Med Microbiol 18 (1984) 335-345
21. Krook A., Danielsson D., Kjellander J., and Jarnerot G. Changes in the fecal flora of patients with Crohn's disease during treatment with metronidazole. A preliminary report. Scand J Gastroenterol 14 (1979) 705-710
22. Castiglione F., Rispo A., Di Girolamo E., et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther 18 (2003) 1107-1112
23. Prantera C., Berto E., Scribano M.L., and Falasco G. Use of antibiotics in the treatment of active Crohn's disease: Experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 30 (1998) 602-606
24. Greenbloom S.L., Steinhart A.H., and Greenberg G.R. Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 12 (1998) 53-56
25. Ishikawa T., Okamura S., Oshimoto H., et al. Metronidazole plus ciprofloxacin therapy for active Crohn's disease. Intern Med 42 (2003) 318-321
26. Prantera C., Zannoni F., Scribano M.L., et al. An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 91 (1996) 328-332
27. Ursing B., Alm T., Barany F., et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: The Cooperative Crohn's Disease Study in Sweden. II. Result. Gastroenterology 83 (1982) 550-562
28. Colombel J.F., Lemann M., Cassagnou M., et al., Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Am J Gastroenterol 94 (1999) 674-678